Table 2.

Hemodynamic and Metabolic Placenta Features

	Mean Perfusion	MTT	VoD	$\frac{\mathit{L}\mathit{a}\mathit{c}\mathit{t}\mathit{a}\mathit{t}\mathit{e}\hspace{0.17em}\mathit{A}\mathit{U}\mathit{C}}{\mathit{P}\mathit{y}\mathit{r}\mathit{u}\mathit{v}\mathit{a}\mathit{t}\mathit{e}\hspace{0.17em}\mathit{A}\mathit{U}\mathit{C}}$	LDH Activity	LDH mRNA	MCT1	MCT4
	mL/100 mL/Min	s	mL/100 mL	Ratio	U/μg	LDH/RPL22 Ratio	MCT1/RPL22 Ratio	MCT4/RPL22 Ratio
Placenta 1	40.8	31.2	17.8	0.034	15e3 ± 11e3	0.19 ± 0.09	1.6 ± 1.4	0.02 ± 0.01
Placenta 2	41.1	14.6	9.5	0.018	2e3 ± 1e3	0.06 ± 0.03	1.5 ± 0.4	0.01 ± 0.01
Placenta 3	43.8	32.6	23.0	0.052	14e3 ± 11e3	0.12 ± 0.11	2.2 ± 0.6	0.01 ± 0.02

Abbreviations: MTT, mean perfusion, mean transit time; VoD, volume of distribution; AUC, lactate-to-pyruvate area under curve ratio. Ex Vivo Biopsy Assays. Lactate dehydrogenase (LDH) Activity and LDH mRNA Expression. Monocarboxylate transporter (MCT) 1 and MCT4 mRNA Expression.